Lana Gettman
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Cooper Institute (1982)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Lana Gettman's research and publications focus on advancements in pharmaceutical treatments, particularly for chronic and infectious diseases. Her recent work includes reviews of novel drugs such as Lecanemab-irmb for Alzheimer's disease and Tirzepatide for type 2 diabetes. She has also published on Finerenone, Difelikefalin, and Avacopan, as well as Faricimab-svoa for macular degeneration and Omidenepag Isopropyl for glaucoma. Gettman has also contributed to the understanding of treatments for SARS-CoV-2, with publications detailing three novel therapies. Beyond drug development, her scholarly interests extend to pharmacy education, including a focus on implementing proactive support models to enhance student success and assessing skills in interpreting culture and sensitivity reports. Gettman's scholarship metrics include an h-index of 5 and 14 total publications.
Metrics
- h-index: 5
- Publications: 14
- Citations: 64
Selected Publications
-
Developing professional etiquette and networking skills in pharmacy students: Evaluation of an etiquette dinner program (2026)
-
Practicing and Assessing Skills of Interpreting Culture and Sensitivity Reports (2025)Scholar Works at Harding (Harding University Main Campus) OpenAlex
-
Lecanemab-irmb (Leqembi™) for Treatment of Alzheimer’s Disease (2024)
-
New Drugs: Faricimab-svoa (Vabysmo<sup>™</sup>) for Macular Degeneration and Diabetic Macular Edema and Omidenepag Isopropyl (Omlonti<sup>™</sup>) for Glaucoma and Ocular Hypertension (2023)
-
New Drug: Tirzepatide (Mounjaro<sup>™</sup>) (2023)
-
New Drugs Update: Three Novel Treatments for SARS-CoV-2 (2022)
-
New Drugs Update: Finerenone, Difelikefalin, and Avacopan (2022)
-
New Drugs (2021)
-
Aspire to be smoke-free pilot study: A prevention educationaloutreach serving preschool children in rural Arkansas (2020)
-
Descriptive Analysis of Acceptance by Prescribers and Economic Benefit of Pharmacist Recommended Interventions in a Critical Care Unit (2018)
Collaboration Network
Top Collaborators
- Advancing Student Success: Implementation of a Proactive Support Model at a College of Pharmacy
- Advancing Student Success: Implementation of a Proactive Support Model at a College of Pharmacy
- Advancing Student Success: Implementation of a Proactive Support Model at a College of Pharmacy
Similar Researchers
Based on overlapping research topics